Template:Fosinopril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
* [[Fosinopril tablet|Fosinopril sodium tablet]] | * [[Fosinopril tablet|Fosinopril sodium tablet]] | ||
===''[[Fosinopril and Hydrochlorothiazide]]''=== | ===''[[Fosinopril and Hydrochlorothiazide tablet|Fosinopril and Hydrochlorothiazide]]''=== | ||
* [[Fosinopril and Hydrochlorothiazide tablet|Fosinopril sodium and Hydrochlorothiazide tablet]] | * [[Fosinopril and Hydrochlorothiazide tablet|Fosinopril sodium and Hydrochlorothiazide tablet]] | ||
Latest revision as of 13:36, 9 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]
Fosinopril
Fosinopril and Hydrochlorothiazide
Overview
Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.